These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23203129)

  • 1. Targeting death receptor TRAIL-R2 by chalcones for TRAIL-induced apoptosis in cancer cells.
    Szliszka E; Jaworska D; Ksek M; Czuba ZP; Król W
    Int J Mol Sci; 2012 Nov; 13(11):15343-59. PubMed ID: 23203129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic flavanones augment the anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Szliszka E; Kostrzewa-Susłow E; Bronikowska J; Jaworska D; Janeczko T; Czuba ZP; Krol W
    Molecules; 2012 Oct; 17(10):11693-711. PubMed ID: 23027370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells.
    Szliszka E; Mazur B; Zydowicz G; Czuba ZP; Król W
    Folia Histochem Cytobiol; 2009; 47(4):579-85. PubMed ID: 20430723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells.
    Szliszka E; Czuba ZP; Mazur B; Sedek L; Paradysz A; Krol W
    Int J Mol Sci; 2009 Dec; 11(1):1-13. PubMed ID: 20161998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells.
    Szliszka E; Czuba ZP; Mazur B; Paradysz A; Krol W
    Molecules; 2010 Aug; 15(8):5336-53. PubMed ID: 20714300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coumarin psoralidin enhances anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Bronikowska J; Szliszka E; Jaworska D; Czuba ZP; Krol W
    Molecules; 2012 May; 17(6):6449-64. PubMed ID: 22643355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.
    Szliszka E; Helewski KJ; Mizgala E; Krol W
    Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis.
    Szliszka E; Zydowicz G; Mizgala E; Krol W
    Int J Oncol; 2012 Sep; 41(3):818-28. PubMed ID: 22735465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
    Szliszka E; Krol W
    Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Szliszka E; Zydowicz G; Janoszka B; Dobosz C; Kowalczyk-Ziomek G; Krol W
    Int J Oncol; 2011 Apr; 38(4):941-53. PubMed ID: 21286663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
    Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
    Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Prostate Cancer Cells after Treatment with Xanthohumol-A Natural Compound Present in Humulus lupulus L.
    Kłósek M; Mertas A; Król W; Jaworska D; Szymszal J; Szliszka E
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.
    Gasparian ME; Bychkov ML; Yagolovich AV; Dolgikh DA; Kirpichnikov MP
    Biochemistry (Mosc); 2015 Aug; 80(8):1080-91. PubMed ID: 26547077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation.
    Moon DO; Kim MO; Choi YH; Kim GY
    Mol Cancer Ther; 2010 Jun; 9(6):1583-95. PubMed ID: 20515942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
    Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel humanized anti-tumor necrosis factor-related apoptosis-inducing ligand-R2 monoclonal antibody induces apoptotic and autophagic cell death.
    Chen L; Qiu Y; Hao Z; Cai J; Zhang S; Liu Y; Zheng D
    IUBMB Life; 2017 Sep; 69(9):735-744. PubMed ID: 28748573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer.
    Huang M; Zhu H; Yi C; Yan J; Wei L; Yang X; Chen S; Huang Y
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):829-838. PubMed ID: 30167846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.